Advanced in Clubbing of the Fingers or Toes

Michael Osthoff

Winterthur, ZH, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Clubbing of the Fingers or Toes
Winterthur, ZH, CH 
OverviewLocationsClinical Research

Overview

Michael Osthoff practices in Winterthur, Switzerland. Mr. Osthoff is rated as an Advanced expert by MediFind in the treatment of Clubbing of the Fingers or Toes. His top areas of expertise are Sepsis, Clubbing of the Fingers or Toes, Pneumonia, Severe Acute Respiratory Syndrome (SARS), and Bone Marrow Transplant.

His clinical research consists of co-authoring 119 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Clubbing of the Fingers or Toes.

Gender
Male

Locations

Winterthur, ZH 8400, Switzerland
Other Locations
Basel, BS, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation: a Multi-center, Randomized, Double-blind, Placebo-controlled Investigational Study (PAIR-TAVI).
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation: a Multi-center, Randomized, Double-blind, Placebo-controlled Investigational Study (PAIR-TAVI).
Enrollment Status: Recruiting
Publish Date: March 12, 2025
Intervention Type: Drug
Study Drug: Conestat Alfa (Ruconest®)
Study Phase: Phase 2
Leptospirosis, Tularaemia and Hepatitis E in a Rural Mountain Valley in the Alpine Region of Switzerland - A Cross-sectional Exploratory Seroprevalence Study
Leptospirosis, Tularaemia and Hepatitis E in a Rural Mountain Valley in the Alpine Region of Switzerland - A Cross-sectional Exploratory Seroprevalence Study
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Other
Clinical Impact of Rapid Identification of Positive Blood Cultures vs. Internal Laboratory Standard
Clinical Impact of Rapid Identification of Positive Blood Cultures vs. Internal Laboratory Standard
Enrollment Status: Completed
Publish Date: May 09, 2024
Intervention Type: Diagnostic test
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19: a Randomized, Parallel-group, Open-label, Multi-center Pilot Trial (PROTECT-COVID-19).
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19: a Randomized, Parallel-group, Open-label, Multi-center Pilot Trial (PROTECT-COVID-19).
Enrollment Status: Terminated
Publish Date: November 09, 2021
Intervention Type: Drug
Study Drug: Conestat alfa
Study Phase: Phase 2
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Contrast-induced Nephropathy in High-risk Subjects (PROTECT): a Randomized, Placebo-controlled, Double-blind Single-center Trial
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Contrast-induced Nephropathy in High-risk Subjects (PROTECT): a Randomized, Placebo-controlled, Double-blind Single-center Trial
Enrollment Status: Completed
Publish Date: August 08, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

119 Total Publications

Vaccination for chronic lung disease
Vaccination for chronic lung disease
Journal: Revue medicale suisse
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Osthoff's expertise for a condition
ConditionClose
      View All 40 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile